117
Views
5
CrossRef citations to date
0
Altmetric
Review

Political advocacy in pharmacy: challenges and opportunities

Pages 89-95 | Published online: 30 Sep 2014

References

  • Gohlke AL, Murphy KM, Cannell ME, Ray DB, Burnworth MJ. Igniting the fire within: a primer on political advocacy for pharmacy professionals. J Pharm Pract. 2013;26(3):165–170.
  • Smith RA. Advocacy, interpretation, and influence in the US. Congress. Am Polit Sci Rev. 1984;78(1):44–63.
  • Richardson E, Pollock AM. Community pharmacy: moving from dispensing to diagnosis and treatment. BMJ. 2010;340:c2298.
  • Thompson CA. California bill would accord pharmacists provider status. Am J Health Syst Pharm. 2013;70(10):839–840.
  • State provider status legislation and initiatives [webpage on the Internet]. Alexandria, VA: American Society of Consultant Pharmacists; 2014. Available from: https://www.ascp.com/providerstatus/states. Accessed June 20, 2014.
  • Gallagher KF, Zander LI. General practitioner and the pharmacist. Br Med J (Clin Res Ed). 1983;287(6389):397–398.
  • Schommer JC, Pedersen CA, Gaither CA, Doucette WR, Kreling DH, Mott DA. Pharmacists’ desired and actual times in work activities: evidence of gaps from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc (2003). 2006;46(3):340–347.
  • Lea VM, Corlett SA, Rodgers RM. Workload and its impact on community pharmacists’ job satisfaction and stress: a review of the literature. Int J Pharm Pract. 2012;20(4):259–271.
  • Laliberte MC, Perreault S, Damestoy N, Lalonde L. Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Public Health. 2012;12:192.
  • Fincham JE, Ahmed A. Dramatic need for cooperation and advocacy within the academy and beyond. Am J Pharm Educ. 2012;76(1):1.
  • Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns [review]. Cochrane Database Syst Rev. 2010;7:CD000336.
  • Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries [review]. Cochrane Database Syst Rev. 2013;2:CD010398.
  • Ballantyne PJ. The role of pharmacists in primary care. BMJ. 2007;334(7603):1066–1067.
  • Medication therapy management [webpage on the Internet]. Baltimore, MD: Centers for Medicare and Medicaid Services; 2014. Available from: http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/MTM.html. Accessed June 20, 2014.
  • Denzin NK, Mettlin CJ. Incomplete professionalization: the case of pharmacy. Soc Forces. 1968;46(3):375–381.
  • Knowlton CH. Pharmacy practice: where’s the value proposition? Pharm Hist. 2009;51(3):94–97.
  • Brushwood DB. Recent trends in pharmacy law and regulation. Pharm Hist. 2009;51(3):98–102.
  • Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582.
  • Davies JE, Barber N, Taylor D. What do community pharmacists do? Results from a work sampling study in London. Int J Pharm Pract. Epub January 14, 2014.
  • Basak SC, van Mil JW, Sathyanarayana D. The changing roles of pharmacists in community pharmacies: perception of reality in India. Pharm World Sci. 2009;31(6):612–618.
  • Gastelurrutia MA, Benrimoj SI, Castrillon CC, de Amezua MJ, Fernandez-Llimos F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009;31(1):32–39.
  • Resnik DB, Ranelli PL, Resnik SP. The conflict between ethics and business in community pharmacy: what about patient counseling? J Bus Ethics. 2000;28(2):179–186.
  • Liberman JN, Hutchins DS, Shrank WH, Slezak J, Brennan TA. Adherence to medication under mandatory and voluntary mail benefit designs. Am J Manag Care. 2011;17(7):e260–e269.
  • Cutrona SL, Choudhry NK, Fischer MA, et al. Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care. 2010;16(12):929–942.
  • Schlozman KL. What accent the heavenly chorus? Political equality and the American pressure system. J Politics. 1984;46(4):1006–1032.
  • O’Brien JM. How nurse practitioners obtained provider status: lessons for pharmacists. Am J Health Syst Pharm. 2003;60(22):2301–2307.
  • Richmond TS, Thompson HJ, Sullivan-Marx EM. Reimbursement for acute care nurse practitioner services. Am J Crit Care. 2000;9(1):52–61.
  • Spitz J, Wickham M. Pharmaceutical high profits: the value of R&D, or oligopolistic rents? Am J Econ Sociol. 2012;71(1):1–36.
  • Quadagno J. Why the United States has no national health insurance: stakeholder mobilization against the welfare state, 1945–1996. J Health Soc Behav. 2004;45 Suppl:25–44.
  • Zellmer WA. Pharmacy’s organizations – key issues for future historians. Pharm Hist. 2009;51(3):127–133.
  • Jorgensen PD. Pharmaceuticals, political money, and public policy: a theoretical and empirical agenda. J Law Med Ethics. 2013;41(3):561–570.
  • About Pfizer [webpage on the Internet]. New York, NY: Pfizer; 2013. Available from: http://www.pfizer.com/about. Accessed April 14, 2014.
  • GSK: about us [webpage on the Internet]. Brentford: GlaxoSmithKline; 2012. Available from: http://us.gsk.com/html/about-us/index.html. Accessed April 14, 2014.
  • Pharmaceuticals [webpage on the Internet]. New Brunswick, NJ: Johnson and Johnson; 2014. Available from: http://www.jnj.com/about-jnj/company-structure/pharmaceutical-companies. Accessed April 14, 2014.
  • Discover Roche [webpage on the Internet]. Basel: Hoffman-La Roche Ltd; 2014. Available from: http://www.roche.com/about_roche/management/ceo_message.htm. Accessed April 14, 2014.
  • Bulow J. The gaming of pharmaceutical patents. In: Jaffe AB, Lerner J, Stern S, editors. Innovation Policy and the Economy, Volume 4. Cambridge, MA: The MIT Press; 2004:145–187.
  • Kendall B. DOJ shifts policy on generic drug patent settlements. The Wall Street Journal. 2009 July 6. Available from: http://online.wsj.com/news/articles/SB124691728092502381. Accessed June 20, 2014.
  • Gray T, Bertch K, Galt K, et al. Guidelines for therapeutic interchange – 2004. Pharmacotherapy. 200525(11):1666–1680.
  • Katz MH. Tobacco-free pharmacies: can we extend the ban? Tob Control. 2013;22(6):363–364.
  • Patwardhan P, McMillen R, Winickoff JP. Consumer perceptions of the sale of tobacco products in pharmacies and grocery stores among US adults. BMC Res Notes. 2013;6:261.
  • Seidenberg AB, Behm I, Rees VW, Connolly GN. Cigarette sales in pharmacies in the USA (2005–2009). Tob Control. 2012;21(5):509–510.
  • Fincham JE. An unfortunate and avoidable component of American pharmacy: tobacco. Am J Pharm Educ. 2008;72(3):57.
  • Els C. Canada: pharmacy tobacco sales to mentally ill people. Tob Control. 2007;16(2):75.
  • Kotecki JE. Sale of alcohol in pharmacies: results and implications of an empirical study. J Community Health. 2003;28(1):65–77.
  • Latif DA. The relationship between pharmacists’ tenure in the community setting and moral reasoning. J Bus Ethics. 2001;31(2):131–141.
  • Smith MA, Bell HS, Kissack JC, Hall PD, Mackinnon GE, Lang WG. Report of the 2012–2013 standing committee on advocacy: advocacy tools and resources: a framework for increasing member engagement. Am J Pharm Educ. 2013;77(10):S17.